Lonza’s $1.2B Roche Biologics Plant Buy Reshapes CDMO Market
Lonza, a leading Swiss contract development and manufacturing organization (CDMO), has acquired
Lonza, a leading Swiss contract development and manufacturing organization (CDMO), has acquired
Medivir AB continues to make significant progress in its preparations for the
Larimar Therapeutics’ experimental drug nomlabofusp has shown promising results in its Phase
Medigene AG, a leading immuno-oncology platform company, announced its financial results and
Medivir AB, a leading pharmaceutical company dedicated to developing groundbreaking treatments for
GenScript, a global biotech leader, showcased its cutting-edge AI capabilities in recombinant
Vertex Pharmaceuticals Incorporated and TreeFrog Therapeutics have entered into a licensing agreement
As the race to treat metabolic dysfunction–associated steatohepatitis (MASH) intensifies, two biotech
La Jolla Institute for Immunology, a world-renowned research institute, and RevolKa Ltd.,
TaiGen Biotechnology Company, Limited, a leading biopharmaceutical company, has announced that its
Genentech, a member of the Roche Group, has announced compelling one-year data
Spago Nanomedical AB, a leading biotech company, has announced the strategic appointment
Rakuten Medical, Inc. recently presented a poster at the 115th Annual Meeting
Nuevocor, a pioneering pre-clinical stage biotechnology company focusing on developing innovative therapies
Pharmaceutical companies are losing significant revenue due to inadequate customer data management
Diakonos Oncology’s unique dendritic cell vaccine, DOC1021, has shown promising results in
The first quarter of 2024 saw a flurry of activity in the
Sirona Biochem Corp., a leading biotech company, has successfully closed its private
PolTREG S.A., a leading biotech company, has published groundbreaking data in the

FDA Approves Abbott’s i-STAT TBI Whole Blood Rapid Test to Assess Patients